Abstract
Aims
To review clinical experience, efficacy, and safety of transluminal Nd:YAG laser embolectomy/embolysis (TYE) for retinal artery occlusion. Methods: Electronic databases were searched for all published clinical studies and case-reports reporting on TYE in central (CRAO) or branch (BRAO) retinal artery occlusion. Individual patient data was evaluated in a weighted pooled analysis.
Results
Sixty-one cases were reported, 47 with BRAO and 14 with CRAO. Visual acuity (VA) at onset averaged 20/252 (1.1 LogMAR) and improved following the procedure to 20/47 (0.37 LogMAR) at first follow-up (avg. 6 days, P < 0.001) and to 20/30 (0.18 LogMAR) at last reported follow-up (avg. 1.1 years, P = 0.02). Patients with worse VA (<20/200) improved further (12 vs. three lines, P < 0.001). VA was not improved when using higher pulse energies (≥ 2.4 mJ) which were associated with more vitrectomies. In a weighted analysis vitreous/sub-retinal hemorrhage was estimated to occur in 54% of cases and required vitrectomy in 18% of cases.
Conclusions
TYE was followed by significant visual improvement in the vast majority of cases, including CRAO, and was frequently associated with vitreous hemorrhage. Patients with poor visual acuity appear to benefit further and higher pulse energies may be detrimental. Lack of randomization and intrinsic biases prevent any definite conclusions regarding the benefits and further research is warranted.
Similar content being viewed by others
References
Cugati S, Varma DD, Chen CS, Lee AW (2012) Treatment options for central retinal artery occlusion. Curr Treat Options Neurol 15(1):63–77. doi:10.1007/s11940-012-0202-9
Varma DD, Cugati S, Lee AW, Chen CS (2013) A review of central retinal artery occlusion: clinical presentation and management. Eye 27(6):688–697. doi:10.1038/eye.2013.25
Schumacher M, Schmidt D, Jurklies B, Gall C, Wanke I, Schmoor C, Maier-Lenz H, Solymosi L, Brueckmann H, Neubauer AS, Wolf A, Feltgen N (2010) Central retinal artery occlusion: local intra-arterial fibrinolysis versus conservative treatment, a multicenter randomized trial. Ophthalmology 117(7):1367–1375.e1361. doi:10.1016/j.ophtha.2010.03.061
Opremcak E, Rehmar AJ, Ridenour CD, Borkowski LM, Kelley JK (2008) Restoration of retinal blood flow via translumenal Nd : YAG Embolysis/embolectomy (TYL/E) for central and branch retinal artery occlusion. Retina J Ret Vit Dis 28(2):226–235
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339:b2700. doi:10.1136/bmj.b2700
Beck RW, Maguire MG, Bressler NM, Glassman AR, Lindblad AS, Ferris FL (2007) Visual acuity as an outcome measure in clinical trials of retinal diseases. Ophthalmology 114(10):1804–1809. doi:10.1016/j.ophtha.2007.06.047
Bravata DM, Olkin I (2001) Simple pooling versus combining in meta-analysis. Eval Health Prof 24(2):218–230. doi:10.1177/01632780122034885
Schulze-Bonsel K, Feltgen N, Burau H, Hansen L, Bach M (2006) Visual acuities “hand motion” and “counting fingers” can be quantified with the Freiburg visual acuity test. Invest Opthalmol Vis Sci 47(3):1236–1240. doi:10.1167/iovs.05-0981
Opremcak EM, Benner JD (2002) Translumenal Nd : YAG laser embolysis for branch retinal artery occlusion. Retina J Ret Vit Dis 22(2):213–216. doi:10.1097/00006982-200204000-00013
Lu N, Yang QS, Ma K, Zhou HY, Xiong Y, Yan W (2006) Preliminary report of Nd: YAG laser embolysis for branch retinal artery occlusion. Zhonghua Yan Ke Za Zhi 42(4):326–329
Mason JO, Nixon PA, Albert MA (2007) Trans-luminal Nd : YAG laser embolysis for branch retinal artery occlusion. Retina J Ret Vit Dis 27(5):573–577. doi:10.1097/Iae.0b013e3180546c4d
Selaru D, Radocea R, Stanca H (2008) Inferior temporal branch arterial occlusion--acute form. Oftalmologia 52(1):64–71
Lim JY, Lee JY, Chung HW, Yoon YH, Kim J-G (2009) Treatment of branch retinal artery occlusion with transluminal Nd:YAG laser Embolysis. Korean J Ophthalmol 23(4):315. doi:10.3341/kjo.2009.23.4.315
Shalchi MH, Daneshvar R (2009) Transluminal Nd:YAG laser embolysis in a case of hemiretinal arterial occlusion. East Mediterr Health J 15(6):1613–1616
Koçak N, Kaynak S, Biçer I, Kaynak T, Yucad G (2012) Transluminal Nd: YAG laser Embolysis for branch retinal artery occlusion: a case report. Turk J Ophthalmol 42:303–305. doi:10.4274/tjo.42.25633
Hsu T-K, Chen S-J, Lei J, Wu Z, Lin C-C, Chen M-M, Lin T-C, Liu J-H, Chao H-M (2013) Embolus-induced branch retinal artery occlusion with a presenting best-corrected visual acuity of <6/12 and visual field defect. Retin Cases Brief Rep 7(3):210–216. doi:10.1097/ICB.0b013e3182852370
Stanca HT, Petrovic Z, Munteanu M (2014) Transluminal Nd:YAG laser embolysis - a reasonable method to reperfuse occluded branch retinal arteries. Vojnosanit Pregl 71(11):1072–1077. doi:10.2298/Vsp130511056s
Much M, Hesse L (2014) Ophthalmologe 111(2):144–150. doi:10.1007/s00347-013-2803-4
Mukhtar A, Malik S, Khan MS, Ishaq M (2016) Nd YAG laser Embolysis in a young woman with Hemiretinal artery occlusion. J Coll Physicians Surg Pak 26(7):629–630
Solans Pérez-Larraya AM, Ortega-Molina JM, Salgado-Miranda AD, García-Serrano JL (2016) Branch retinal artery occlusion in a patient with one eye. Laser Nd:YAG approach. Arch Soc Esp Oftalmol. doi:10.1016/j.oftal.2016.01.002
Matušková V, Vysloužilová D, Vlková E (2016) L’utilisation du laser Nd YAG pour le traitement de l’occlusion de la branche de l’artère centrale de la rétine. J Fr Ophtalmol 39(5):e115–e117. doi:10.1016/j.jfo.2015.04.027
Reynard M, Hanscom TA (2004) Neodymium : yttrium-aluminum-garnet laser arteriotomy with embolectomy for central retinal artery occlusion. Am J Ophthalmol 137(1):196–198. doi:10.1016/S0002-9394(03)00817-1
Feist RM, Emond TL (2005) Translumenal ND : YAG laser embolysis for central retinal artery occlusion. Retina J Ret Vit Dis 25(6):797–799. doi:10.1097/00006982-200509000-00022
Haritoglou C, Wolf A, Ulbig MW (2010) Laser embolectomy for central retinal artery occlusion. Ophthalmologe 107(5):465–467. doi:10.1007/s00347-009-2078-y
Akduman L, Currie M, Scanlon C, Grant A, Cetin EN (2013) Nd-Yag laser Arteriotomy for central retinal artery occlusion. Retin Cases Brief Rep 7(4):325–327. doi:10.1097/ICB.0b013e31828ef0f2
Dutton GN, Craig G (1989) Treatment of a retinal embolus by photocoagulation. Brit J Ophthalmol 73(7):580–581. doi:10.1136/Bjo.73.7.580-A
Hayreh SS (2008) Correspondence. Retina 28(9):1369–1372. doi:10.1097/IAE.0b013e3181846640
Hayreh SS, Weingeist TA (1980) Experimental occlusion of the central artery of the retina. IV: retinal tolerance time to acute ischaemia. Brit J Ophthalmol 64(11):818–825. doi:10.1136/bjo.64.11.818
Hayreh SS, Podhajsky PA, Zimmerman MB (2009) Branch retinal artery occlusion. Ophthalmology 116(6):1188–1194.e1184. doi:10.1016/j.ophtha.2009.01.015
Yuzurihara D, Iijima H (2004) Visual outcome in central retinal and branch retinal artery occlusion. Jpn J Ophthalmol 48(5):490–492. doi:10.1007/s10384-004-0102-y
Brown GC, Magargal LE, Shields JA, Goldberg RE, Walsh PN (1981) Retinal arterial-obstruction in children and young-adults. Ophthalmology 88(1):18–25
Hayreh SS, Zimmerman B (2005) Central retinal artery occlusion: visual outcome. Am J Ophthalmol 140(3):376–391. doi:10.1016/j.ajo.2005.03.038
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors.
Conflict of interest
All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.
Ethical approval
All procedures performed in studies involving humanparticipants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study formal consent is not required.
Electronic supplementary material
Supplemental Figure 1
Flow Diagram of the Inclusion Process (DOCX 30 kb)
Rights and permissions
About this article
Cite this article
Man, V., Hecht, I., Talitman, M. et al. Treatment of retinal artery occlusion using transluminal Nd:YAG laser: a systematic review and meta-analysis. Graefes Arch Clin Exp Ophthalmol 255, 1869–1877 (2017). https://doi.org/10.1007/s00417-017-3777-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-017-3777-8